PUBLISHER: The Insight Partners | PRODUCT CODE: 2165981
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165981
The North America Impulse Oscillometry Market is projected to reach US$ 83,159.1 Thousand by 2034, increasing from US$ 51,638.7 Thousand in 2025. The market is anticipated to expand at a CAGR of 5.5% between 2026 and 2034.
Executive Summary and North America Impulse Oscillometry Market Analysis:
The North America impulse oscillometry market, comprising the US, Canada, and Mexico, is witnessing growth driven by increasing exposure to air pollution, smoking, and occupational respiratory hazards, which are contributing to the rising prevalence of respiratory disorders and the need for advanced pulmonary diagnostic solutions. The growing elderly population in the US and Canada is particularly vulnerable to chronic respiratory conditions, further increasing the demand for accurate, noninvasive diagnostic technologies such as impulse oscillometry. Advancements in pulmonary function testing systems, including enhanced sensitivity, portability, ease of operation, and improved user interfaces, are supporting broader adoption across hospitals, specialty clinics, and research facilities. Increasing awareness among healthcare professionals regarding the advantages of IOS, including its minimal patient effort requirements and suitability for pediatric and geriatric patients, is further supporting market development. In addition, favorable reimbursement frameworks, well-established healthcare infrastructure, and high healthcare spending across North America facilitate the adoption of sophisticated diagnostic equipment. Continued clinical research, emphasis on early respiratory disease diagnosis, and the presence of leading medical device companies in the region are also fostering technological innovation and commercialization.
Strategic Insights
North America Impulse Oscillometry Market Segmentation Analysis:
By Product, the North America Impulse Oscillometry Market is categorized into Device and Accessories. The Device segment accounted for the largest market share in 2025.
By Device for Product, the market is divided into Desktop and Portable. The Desktop segment dominated the market in 2025.
By Accessories for Product, the market includes Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment held the leading position in 2025.
By Application, the North America Impulse Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
By End User, the market is categorized into Hospitals and Clinics, Diagnostic Laboratories, and Other End Users. The Hospitals and Clinics segment held the largest share in 2025.
Market Report Scope
North America Impulse Oscillometry Market Outlook
The increasing global burden of respiratory diseases is creating significant opportunities for impulse oscillometry as a noninvasive pulmonary diagnostic technology. According to the Global Initiative for Chronic Obstructive Lung Disease, approximately 65 million people are affected by obstructive pulmonary disease globally, while nearly 3 million deaths occur annually due to the condition, making it one of the leading causes of mortality worldwide. Data from the American Lung Association in 2023 indicated that approximately 34 million Americans were living with chronic respiratory diseases, including asthma and COPD. Globally, asthma affects more than 339 million people, according to the Global Initiative for Asthma, supporting the need for diagnostic technologies such as IOS that can evaluate airway resistance and reactance without requiring forceful breathing maneuvers. Respiratory problems have also increased in highly polluted urban environments, including cities across India and China. Furthermore, IOS has demonstrated utility in monitoring conditions such as cystic fibrosis, with the Cystic Fibrosis Foundation estimating more than 70,000 affected individuals worldwide.
In developing markets, the continued prevalence of tuberculosis, which accounts for millions of new cases annually according to the World Health Organization, creates additional opportunities for pulmonary diagnostic technologies capable of distinguishing different respiratory patterns. IOS can assist in identifying obstructive and restrictive respiratory abnormalities, potentially supporting more targeted disease management. Occupational respiratory disorders associated with industries such as mining and agriculture further contribute to the global respiratory disease burden. The International Labour Organization estimates approximately 2.78 million work-related deaths each year, with respiratory conditions representing an important component of occupational health risks. Consequently, the increasing prevalence of respiratory diseases is strengthening the role of impulse oscillometry in early diagnosis, monitoring, and proactive respiratory healthcare across diverse patient populations.
North America Impulse Oscillometry Market Country Insights
By country, the North America Impulse Oscillometry Market is segmented into the United States, Canada, and Mexico. The United States held the largest market share in 2025.
Impulse oscillometry is a noninvasive pulmonary function assessment that evaluates airway resistance and reactance during normal tidal breathing. This makes the technology particularly beneficial for diagnosing and monitoring respiratory conditions such as asthma and COPD among patients who may have difficulty performing conventional spirometry, including children and individuals with severe airflow obstruction. In the US, approximately 24.9 million people were affected by asthma in 2021, comprising around 4.7 million children and 20.3 million adults, according to CDC data. In addition, the American Lung Association reported in 2023 that approximately 34 million Americans were living with chronic lung diseases, including COPD. COPD contributes to more than 135,000 deaths annually in the country, creating a substantial healthcare burden and supporting the demand for advanced respiratory diagnostic tools.
IOS offers an additional clinical advantage by identifying small airway dysfunction that may not be adequately captured through conventional spirometry. It can also provide information regarding bronchodilator response and disease control. Recent clinical research has further supported the role of IOS in respiratory disease assessment. A 2024 review published in BMJ Open Respiratory Research identified correlations between IOS and conventional pulmonary function testing in asthma and COPD, while also highlighting its potential application in evaluating small airway involvement and incorporating artificial intelligence into analysis. A 2025 study published in BMC Pulmonary Medicine demonstrated the usefulness of IOS in detecting small airway dysfunction among patients with preserved ratio impaired spirometry and COPD, with R5-R20 providing meaningful diagnostic thresholds. Another 2025 study in Diagnostics reported significant correlations between IOS and body plethysmography in obstructive patient groups. These developments are contributing to the increasing integration of IOS into US healthcare settings for more comprehensive respiratory assessment while reducing the need for maximal patient effort.
North America Impulse Oscillometry Market Company Profiles
Key companies operating in the North America Impulse Oscillometry Market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, GANSHORN Medizin Electronic GmbH, Vitalograph Ltd, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.
These companies are pursuing strategies such as geographic expansion, technological and product innovation, strategic partnerships, and mergers and acquisitions to strengthen their product portfolios, address evolving respiratory diagnostic requirements, and expand their market presence.